Table 2.
Examples of scenarios compatible with systemic secondary hyperfibrinolysis.
| Systemic secondary hyperfibrinolysis: clot weakening and exhaustion of fibrinolysis inhibitors after extreme and prolonged coagulation activation | |
|---|---|
| Mechanism | Compatible scenarios |
| Coagulation is activated anomalously and dissociatedly from fibrinolysis (DIC) | Sepsis |
| Tissue factor-expressing neoplasms (mucinous adenocarcinomas, malignant brain tumors and acute promyelocytic leukemia) | |
| Obstetric complications (retained products of conception, pre-eclampsia, amniotic embolism, placenta praevia) | |
| Major tissue damage causing intense, sustained and orchestrated activation of coagulation and fibrinolysis | Major trauma |
| Major non-cardiac surgeries | |
| Major cardiovascular surgeries | |
| Postpartum hemorrhage (placental abruption, uterine atony or rupture, placenta praevia, placenta accreta) | |